Clinical Coverage/Medical Policy Updates
WellCare of North Carolina updates a select number of clinical coverage policies each month, ensuring the reviewal of all policies on an annual basis.
Policy Updates
- WNC.CPG Clinical Practice and Preventive Health Guidelines (PDF)
- WNC.CP.104 Breast Surgeries (PDF)
- WNC.CP.108 Physical Rehabilitation Equipment and Supplies (PDF)
- WNC.CP.121 Optic Nerve Decompression Surgery (PDF)
- WNC.CP.122 Total Artificial Heart (PDF)
- WNC.CP.125 Fecal Incontinence Treatments (PDF)
- WNC.CP.131 Phototherapy for Neonatal Hyperbilirubinemia (PDF)
- WNC.CP.163 NICU Discharge Guidelines (PDF)
- WNC.CP.167 Neonatal Sepsis Management (PDF)
- WNC.CP.168 Neonatal Abstinence Syndrome Guidelines (PDF)
- WNC.CP.181 Fluorescein Angiography (PDF)
- WNC.CP.183 Gonioscopy (PDF)
- WNC.CP.184 External Ocular Photography (PDF)
- WNC.CP.185 Visual Field Testing (PDF)
- WNC.CP.186 Teleretinal Screening for Diabetic Retinopathy (PDF)
- WNC.CP.258 Inpatient Behavioral Health Services (PDF)
- WNC.CP.265 Caudal or Interlaminar Epidural Steroid Injections (PDF)
- WNC.CP.267 Facet Joint Interventions (PDF)
- WNC.CP.275 Chiropractic Services (PDF)
- WNC.CP.115 Routine Patient Costs Furnished in Connection with Participation in Qualifying Clinical Trials (PDF)
- WNC.CP.129 Electric Tumor Treating Fields (PDF)
- WNC.CP.133 Digital EEG Spike Analysis (PDF)
- WNC.CP.232 Ventricular Assist Devices (PDF)
- WNC.CP.238 Hematopoietic Stem-Cell Transplantation for Leukemia (PDF)
- WNC.CP.239 Hematopoietic Stem-CellTransplantation for Lymphoma (PDF)
- WNC.CP.240 Hematopoietic Stem-Cell Transplantation for Solid Tumors of Childhood (PDF)
- WNC.CP.241 Allogeneic Hematopoietic Stem Cell Transplantation for Genetic Diseases and Acquired Anemias (PDF)
- WNC.CP.242 Hematopoietic Stem-Cell Transplantation in the Treatment of Germ Cell Tumors (PDF)
- WNC.CP.243 Hematopoietic Stem-Cell Transplantation For Multiple Myeloma POEMS Syndrome and Primary Amyloidosis (PDF)
- WNC.CP.244 Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes Myeloproliferative Neoplasms (PDF)
- WNC.CP.245 Hematopoietic Stem-Cell Transplantation (HSCT) for Central Nervous System (CNS) Embryonal Tumors Ependymoma (PDF)
- WNC.CP.277 Opioid Treatment Program Service (PDF)
- WNC.CP.103 Physician Fluoride Varnish Services (PDF)
- WNC.CP.114 Enhanced Mental Health and Substance Abuse Services (PDF)
- WNC.CP.141 Measurement of Serum 125-Dihydroxyvitamin D (PDF)
- WNC.CP.144 EEG in the Evaluation of Headache (PDF)
- WNC.CP.145 Cardiac Biomarker Testing (PDF)
- WNC.CP.156 Diaphragmatic Phrenic Nerve Stimulation (PDF)
- WNC.CP.262 Non-Emergency Medical Transportation (PDF)
- WNC.CP.274 Pulmonary Function Testing (PDF)
- WNC.CP.281 Medically Monitored Inpatient Withdrawal Management Services (ASAM 3.7 WM) (PDF)
- WNC.CP.289 Ambulatory Withdrawal Management Without Extended Onsite Monitoring (ASAM 1 WM) (PDF)
- WNC.CP.290 Ambulatory Withdrawal Management With Extended On-Site Monitoring (ASAM 2 WM) (PDF)
- WNC.CP.297 Physical Health Clinical Policy Committee (PDF)